Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease

NIH RePORTER · NIH · OT2 · $1,200,379 · view on reporter.nih.gov ↗

Abstract

No abstract provided

Key facts

NIH application ID
10083551
Project number
1OT2HL154815-01
Recipient
BOSTON CHILDREN'S HOSPITAL
Principal Investigator
DAVID A WILLIAMS
Activity code
OT2
Funding institute
NIH
Fiscal year
2020
Award amount
$1,200,379
Award type
1
Project period
2020-07-22 → 2025-09-30